Dramatic improvement of left ventricular function after cytotoxic therapy in lupus patients with acute cardiomyopathy: Report of 6 cases

Journal of Rheumatology

Volumn 26, Issue 10, 1999, Pages 2257-2260

  Naarendorp, Michael ^a   Kerr, Leslie Dubin ^a   Khan, Asim S ^a   Ornstein, Matthew H ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Cardiomyopathy; Left ventricular function; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISONE;

ADULT; ARTHRITIS; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE FUNCTION; HUMAN; MYALGIA; NEPHRITIS; PERICARDITIS; PLEURISY; PRIORITY JOURNAL; RASH; SYSTEMIC LUPUS ERYTHEMATOSUS;

ACUTE DISEASE; ADULT; ANTI-INFLAMMATORY AGENTS; AZATHIOPRINE; CARDIOMYOPATHIES; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREDNISONE; RETROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 0032875710     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Chang RW. Cardiac manifestations of SLE. Clin Rheum Dis 1982;8:197-206.
2. Griffith GC, Vural IL. Acute and subacute disseminated lupus erythematosus: a correlation of clinical and postmortem findings in 18 cases. Circulation 1951;3:492.
3. Harvey A, Schulman L, Tumulty P, Conley C, Scheinrick E. Systemic lupus erythematosus: Review of the literature and clinical analysis of 138 cases. Medicine 1954;33:291.
4. Shearn M. The heart in systemic lupus erythematosus. Am Heart J 1959;58:452.
5. Larson DL. Systemic lupus erythematosus. Boston: Little, Brown & Co;1961.
6. Kong TQ, Kellum RE, Haserich JR. Clinical diagnosis of cardiac involvement in systemic lupus erythematosus: a correlation of clinical and autopsy findings in 30 patients. Circulation 1962;26:7.
7. Hejtmancik M, Wright J, Quint R, Jemmings F. The cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 1964;68:119.
8. Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: A study of 36 necropsy patients. Am J Med 1975;58:243.
9. Dubois EL. Prednisone and prednisolone in the treatment of lupus erythematosus. JAMA 1956;161:427.
10. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine 1971;50:85.
11. Dubois E. Lupus erythematosus: a review of the current status of discoid and systemic lupus erythematosus and their variants. 2nd ed. Los Angeles: University of Southern California Press; 1976.
12. Ropes M. Systemic lupus erythematosus. Cambridge: Harvard University Press; 1976.
13. McGehee Harvey A, Shulman LE, Tumulty AP, Lockard Conley C, Schoenrich EH. Systemic lupus erythematosus: review of literature and clinical analysis of 138 cases. Medicine 1954;33:291-437.
14. O'Connell JB, Mason JW. The roles of endomyocardial biopsy and gallium 67 scintigraphy in the assessment and treatment of active myocarditis, in cardiomyopathy. Update 1: pathogenesis of myocarditis and cardiomyopathy. Tokyo: University of Tokyo Press; 1987:281-92.
15. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 1990;112:682-98.
16. Kerr LD, Spiera H. Myocarditis as a complication in scleroderma patients with myositis. Clin Cardiol 1993;16:895-9.
17. Borenstein DG, Fye WB, Arnett FC, Stevens MB. Myocarditis of SLE: association with myocarditis. Ann Intern Med 1978;89:619.
18. Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995;333:269-75.